Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

A doctor from the University of Palermo in Italy has published a case study of an adult cocaine user who experienced reduced ...

New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption.

American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic ...

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

Desperation for ‘weight-loss’ drug that’s used to treat type-2 diabetes is real. Break-ins at pharmacies have also been ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Hims & Hers Health (NYSE: HIMS) tumbled 5.6% through 12:20 p.m. ET Thursday after Bank of America analysts gave mixed messages on the stock this morning. Raising its price target on the shares to $21, ...

Madison Burgess turned to Ozempic for weight loss in 2023. She saw quick results but developed severe side effects when her dose increased. Switching to microdosing, she ultimately lost 60 lbs.